Detalhe da pesquisa
1.
Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial.
Cardiovasc Diabetol
; 22(1): 330, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38017482
2.
Enhanced expression of ß cell CaV3.1 channels impairs insulin release and glucose homeostasis.
Proc Natl Acad Sci U S A
; 117(1): 448-453, 2020 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31871187
3.
Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trials.
Lancet Rheumatol
; 2(1): e31-e41, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38258274
4.
Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients.
PLoS One
; 13(12): e0208998, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30557325
5.
Human pancreatic islet-derived extracellular vesicles modulate insulin expression in 3D-differentiating iPSC clusters.
PLoS One
; 12(11): e0187665, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29117231
6.
Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes.
Cell Metab
; 24(4): 593-607, 2016 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27667667
7.
Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice.
PLoS One
; 7(5): e37787, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22662222